Hidradenitis suppurativa Trials in Indianapolis, United States
Conditions / Hidradenitis suppurativa / Indianapolis, United States
Clinical trials for Hidradenitis suppurativa investigate a range of treatment strategies and patient populations.
23 total trials for this combination
Showing top 10 of 23 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04179175 | Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis Suppurativa | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT03661866 | A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC | RECRUITING | — |
| NCT06799000 | A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1) | RECRUITING | PHASE3 |
| NCT05819398 | Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa | COMPLETED | PHASE2/PHASE3 |
| NCT06956235 | Study to Evaluate Tulisokibart for Hidradenitis Suppurativa (MK-7240-012) | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT05905783 | Hidradenitis Suppurativa Study of Izokibep | TERMINATED | PHASE3 |
| NCT05889182 | A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy | RECRUITING | PHASE3 |
| NCT03852472 | Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa (AURORA) | COMPLETED | PHASE2 |
| NCT03713632 | Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS) | COMPLETED | PHASE3 |
| NCT06468228 | A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa | RECRUITING | PHASE3 |